Clinical Trial Detail

NCT ID NCT01823835
Title A Study of ARN-810 (GDC-0810) in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements yes
Sponsors Genentech, Inc.
Indications

Her2-receptor negative breast cancer

Therapies

GDC-0810

Age Groups: adult

Additional content available in CKB BOOST